
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 899 | 899 | 942 | 970 | 1371 | 2192 |
Fund Return | -10.14% | -10.14% | -5.82% | -1.02% | 6.52% | 8.16% |
Place in category | 247 | 247 | 312 | 322 | 488 | 108 |
% in Category | 46 | 46 | 58 | 65 | 94 | 33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artisan International Value Instl | 22.54B | 5.54 | 9.97 | 7.95 | ||
Artisan International Value Advisor | 11.43B | 5.50 | 9.87 | - | ||
Artisan Mid Cap Investor | 3.59B | -7.40 | -1.30 | 8.29 | ||
Artisan Mid Cap Advisor | 3.59B | -7.37 | -1.17 | - | ||
Artisan Mid Cap Institutional | 3.59B | -7.35 | -1.08 | 8.54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Explorer Adm | 18.36B | -8.90 | 0.77 | 8.53 | ||
Vanguard Small Cap Growth Index Adm | 14.11B | -9.92 | 1.18 | 7.30 | ||
Neuberger Berman Genesis R6 | 3.96B | -8.31 | 1.83 | 8.38 | ||
T. Rowe Price Instl Small-Cap Stock | 3.86B | -5.87 | 2.24 | 8.68 | ||
T. Rowe Price QM US Small-Cap Gr Eq | 3.86B | -8.07 | 3.49 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Guidewire | US40171V1008 | 4.58 | 190.72 | +1.67% | |
Lattice | US5184151042 | 4.18 | 43.28 | +2.61% | |
Ascendis Pharma AS | US04351P1012 | 4.13 | 150.99 | +5.34% | |
Veracyte Inc | US92337F1075 | 3.45 | 31.80 | +5.12% | |
MACOM Tech | US55405Y1001 | 3.40 | 97.82 | -1.46% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review